Blog 
If you are interested in becoming a frequent blogger on our site, please email Debbie@hepcfund.org.

HCV Vaccine Boosts Response to Standard Treatment

Friday, April 23rd, 2010

Tarmogen Vaccine, GI-5005, increased virologicl response in phase II trial.

http://www.docguide.com/news/content.nsf/news/852576140048867C8525770D0067832B

Financial Help for HCV Treatment

Wednesday, January 6th, 2010

We have been receiving several inquiries on how to get financial assistance for HCV treatment both in the U.S. and abroad. We are not able to provide any money  from the Greenview Hepatitis C Fund for this purpose, but are interested in steering people to available resources.

Most major pharmaceutical companies offer “Patient Assistance Programs” to provide free or low cost medications to those unable to pay. Here are some I found:

Merck/Schering-Plough

http://www.rxassist.org/pap-info/company_detail.cfm?CmpId=124

General search

http://www.pparx.org/prescription_assistance_programs/list_of_participating_programs

Roche

http://www.gene.com/gene/products/access/roche/

Pegasys

http://www.patientassistance.com/B5790-pegasys.html

BioPlus Specialty Pharmacy Services, 376 Northlake Blvd., Altamonte Springs Fl. 32701, U.S. (888-292-0744, Fax: 800-269-5493). Contact me at Debbie@hepcfund.org for the PDF version of their brochure.

If you have been able to get financial help for HCV treatment and you do not see your program listed here, please notify us either in a comment on this blog or email me at Debbie@hepcfund.org.